# Ascorbic Acid Levels in MDS, AML, and CMML Patients

> **NCT03526666** · — · COMPLETED · sponsor: **Van Andel Research Institute** · enrollment: 50 (actual)

## Conditions studied

- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- Chronic Myelomonocytic Leukemia
- MDS
- AML
- CMML

## Interventions

- **OTHER:** Peripheral blood collection

## Key facts

- **NCT ID:** NCT03526666
- **Lead sponsor:** Van Andel Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-10-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03526666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03526666, "Ascorbic Acid Levels in MDS, AML, and CMML Patients". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03526666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*